Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026)
Envista Holdings (NVST) posted quarterly Income from Continuing Operations of 38700000.0 for Q2 2026, up 115.0% year-over-year from 18000000.0 in Q2 2025, and up 17.63% quarter-over-quarter from 32900000.0 in Q4 2025.
Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Envista Holdings' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 38700000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 115.0% year-over-year to 38700000.0; the TTM figure through Apr 2026 stood at 67700000.0 (up 106.02% YoY), while the FY2025 annual figure was 47000000.0, up 104.2% from the prior year.
- Income from Continuing Operations for Q2 2026 stood at 38700000.0, up from 32900000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 73500000.0 in Q4 2022, with the low at 1151600000.0 in Q2 2024.
- The 5-year median for Income from Continuing Operations is 26400000.0 (2025), against an average of 52652941.18.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations sank 2318.88% in 2024, then surged 2641.67% in 2025.
- Envista Holdings' Income from Continuing Operations stood at 73500000.0 in 2022, then slumped by 395.78% to 217400000.0 in 2023, then soared by 100.55% to 1200000.0 in 2024, then soared by 2641.67% to 32900000.0 in 2025, then climbed by 17.63% to 38700000.0 in 2026.
- Business Quant data shows NVST's Income from Continuing Operations at 38700000.0 in Q2 2026, 32900000.0 in Q4 2025, and 30300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Envista Holdings | 4.37 Bn | 3.24 Bn | 407.00 Mn | 53.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 53.70 Mn |
| Apr 3, 2026 | 38.70 Mn |
| Dec 31, 2025 | 32.90 Mn |
| Sep 26, 2025 | -30.30 Mn |
| Jun 27, 2025 | 26.40 Mn |
| Mar 28, 2025 | 18.00 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 27, 2024 | 8.20 Mn |
| Jun 28, 2024 | -1.15 Bn |
| Mar 29, 2024 | 23.60 Mn |
| Dec 31, 2023 | -217.40 Mn |
| Sep 29, 2023 | 21.50 Mn |
| Jun 30, 2023 | 51.90 Mn |
| Mar 31, 2023 | 43.80 Mn |
| Dec 31, 2022 | 73.50 Mn |
| Sep 30, 2022 | 49.60 Mn |
| Jul 1, 2022 | 44.50 Mn |
| Apr 1, 2022 | 70.40 Mn |
| Dec 31, 2021 | 42.50 Mn |
| Oct 1, 2021 | 80.20 Mn |